Back to search

Article

Intranasal Anti-CD3 Antibody Treatment Attenuates Post–COVID Neuroinflammation and Enhances Hippocampal Neurogenesis and Cognitive Function in Mice

2026-04-08

Abstract excerpt

Cognitive impairment is a disabling feature of Long COVID, with data supporting neuroinflammation and maladaptive glial responses as primary drivers. Nasal administration of an anti-CD3 monoclonal antibody (aCD3 mAb) has shown therapeutic benefits in autoimmune and CNS disease models. Using a respiratory-restricted mild SARS-CoV-2 mouse model of Long COVID, we show that nasal anti-CD3 mAb, administered shortly aft...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f517943b-383f-583c-a8e6-b8503dc2052f
DOI
10.64898/2026.04.07.716934
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intranasal Anti-CD3 Antibody Treatment Attenuates Post–COVID Neuroinflammation and Enhances Hippocampal Neurogenesis and Cognitive Function in MiceDOI 10.64898/2026.04.07.716934
Select a neighboring publication to make it the new centre.